Articoli correlati a Controlled Release in Oral Drug Delivery

Controlled Release in Oral Drug Delivery ISBN 13: 9781461410034

Controlled Release in Oral Drug Delivery - Rilegato

 
9781461410034: Controlled Release in Oral Drug Delivery
Vedi tutte le copie di questo ISBN:
 
 
Controlled Release in Oral Drug Delivery provides focus on specific topics, complementing other books in the initial CRS series. Each chapter sets the context for the inventions described and describe the latitude that the inventions allow. In order to provide some similar look to each chapter, the coverage includes the historical overview, candidate drugs, factors influencing design and development, formulation and manufacturing and delivery system design. This volume was written along three main sections: the relevant anatomy and physiology, a discussion on candidates for oral drug delivery and the major three groups of controlled release systems: diffusion control (swelling and inert matrices); environmental control (pH sensitive coatings, time control, enzymatic control, pressure control) and finally lipidic systems.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

L'autore:

Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University in Glasgow, Scotland and the current president of the European Union Federation for Pharmaceutical Sciences. He is the Chief Scientist of Bio-Images Research Group, a Phase II imaging specialist clinical unit in Glasgow Royal Infirmary.

Major areas of research have been the study of the behaviour of drug formulations in man. With colleagues at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects of transit on drug absorption and began the investigations into regional drug absorption in man. This was later applied to the design and optimisation of oral dosage forms, in silico modelling of formulations in man and studies on IVIVR. He has published more than 150 papers, six books and over 130 reviews and book chapters. He was made a fellow of the Controlled Release Society in June 2010 and a Fellow of the Academy of Pharmaceutical Sciences in September 2010.

Patrick Crowley has over 40 years’ experience in dosage form development in the pharmaceutical industry, in both the UK and USA. He has played key roles in the development of 16 commercial products, including fermentation products, semi synthetics, synthetic structures and a biopharmaceutical product and holds several formulation-related Patents. His interests and publications include drug and product stability, enhancing performance by dosage form design and the application of Quality by Design principles and practices in dosage form development, manufacture and control.
Dalla quarta di copertina:

Controlling the rate, extent and time of a drug’s delivery can optimize its performance in many ways, relative to “immediate release” delivery. Such optimized design requires a broad knowledge base of topics such as gastro intestinal tract physiology, polymer science, and the mechanisms by which drugs are released from the formulated units. Technologies to “reduce to practice” also need to be carefully considered. Such knowledge must be allied to the physico chemical properties of the drug, its pharmacokinetic behaviors, enzyme susceptibility and other factors that can affect absorption or timecourse in the biosystem.

Traditionally, controlled release systems tended to be “second-generation products, building on accumulated clinical experience. However, better awareness of the molecular biology of drug action and the promise of biomarkers and personalized medicine may mean that optimizing performance by controlling release may become a first option in new product development. Such optimization may well help reduce the alarming attrition rates that are now prevalent in new drug development.

Controlled Release in Oral Drug Delivery provides chapters, dealing with all facets of the above subject matter, and its challenges. Authors have been drawn from academia, providers of excipients and from those designing controlled release systems in industrial R&D and manufacture. The contents provide a unique blend of cutting edge knowledge, data on materials and practical experiences. It is essential text for students, researchers and industrial engineering, formulation and manufacturing technologists as well as quality testing and control functions.

Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University in Glasgow, Scotland and the current president of the European Union Federation for Pharmaceutical Sciences. He is the Chief Scientist of Bio-Images Research Group, a Phase II imaging specialist clinical unit in Glasgow Royal Infirmary.

Major areas of research have been the study of the behaviour of drug formulations in man. With colleagues at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects of transit on drug absorption and began the investigations into regional drug absorption in man. This was later applied to the design and optimisation of oral dosage forms, in silico modelling of formulations in man and studies on IVIVR. He has published more than 150 papers, six books and over 130 reviews and book chapters. He was made a fellow of the Controlled Release Society in June 2010 and a Fellow of the Academy of Pharmaceutical Sciences in September 2010.

Patrick Crowley has over 40 years’ experience in dosage form development in the pharmaceutical industry, in both the UK and USA. He has played key roles in the development of 16 commercial products, including fermentation products, semi synthetics, synthetic structures and a biopharmaceutical product and holds several formulation-related Patents. His interests and publications include drug and product stability, enhancing performance by dosage form design and the application of Quality by Design principles and practices in dosage form development, manufacture and control.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Spese di spedizione: EUR 11,99
Da: Germania a: Italia

Destinazione, tempi e costi

Aggiungere al carrello

Altre edizioni note dello stesso titolo

9781461430070: Controlled Release in Oral Drug Delivery

Edizione in evidenza

ISBN 10:  ISBN 13:  9781461430070
Casa editrice: Springer, 2013
Brossura

  • 9781461410058: Controlled Release in Oral Drug Delivery

    Springer, 2011
    Brossura

I migliori risultati di ricerca su AbeBooks

Immagini fornite dal venditore

Wilson, Clive G.|Crowley, Patrick J.
Editore: Springer US (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovo Rilegato Quantità: > 20
Print on Demand
Da:
moluna
(Greven, Germania)
Valutazione libreria

Descrizione libro Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Each chapter covers historical overview, candidate drugs, factors influencing design and development, formulation and manufacturing and delivery system design Provides focus on specific topics, complementing other books in the initial CRS series. Codice articolo 4196991

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 180,07
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 11,99
Da: Germania a: Italia
Destinazione, tempi e costi
Immagini fornite dal venditore

Editore: Springer (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovo Rilegato Quantità: 10
Da:
booksXpress
(Bayonne, NJ, U.S.A.)
Valutazione libreria

Descrizione libro Hardcover. Condizione: new. Codice articolo 9781461410034

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 205,12
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 7,41
Da: U.S.A. a: Italia
Destinazione, tempi e costi
Immagini fornite dal venditore

Patrick J. Crowley
Editore: Springer US Sep 2011 (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovo Rilegato Quantità: 2
Print on Demand
Da:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Germania)
Valutazione libreria

Descrizione libro Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Controlling the rate, extent and time of a drug s delivery can optimize its performance in many ways, relative to immediate release delivery. Such optimized design requires a broad knowledge base of topics such as gastro intestinal tract physiology, polymer science, and the mechanisms by which drugs are released from the formulated units. Technologies to reduce to practice also need to be carefully considered. Such knowledge must be allied to the physico chemical properties of the drug, its pharmacokinetic behaviors, enzyme susceptibility and other factors that can affect absorption or timecourse in the biosystem. Traditionally, controlled release systems tended to be second-generation products, building on accumulated clinical experience. However, better awareness of the molecular biology of drug action and the promise of biomarkers and personalized medicine may mean that optimizing performance by controlling release may become a first option in new product development. Such optimization may well help reduce the alarming attrition rates that are now prevalent in new drug development.Controlled Release in Oral Drug Delivery provides chapters, dealing with all facets of the above subject matter, and its challenges. Authors have been drawn from academia, providers of excipients and from those designing controlled release systems in industrial R&D and manufacture. The contents provide a unique blend of cutting edge knowledge, data on materials and practical experiences. It is essential text for students, researchers and industrial engineering, formulation and manufacturing technologists as well as quality testing and control functions. Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University in Glasgow, Scotland and the current president of the European Union Federation for Pharmaceutical Sciences. He is the Chief Scientist of Bio-Images Research Group, a Phase II imaging specialist clinical unit in Glasgow Royal Infirmary.Major areas of research have been the study of the behaviour of drug formulations in man. With colleagues at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects of transit on drug absorption and began the investigations into regional drug absorption in man. This was later applied to the design and optimisation of oral dosage forms, in silico modelling of formulations in man and studies on IVIVR. He has published more than 150 papers, six books and over 130 reviews and book chapters. He was made a fellow of the Controlled Release Society in June 2010 and a Fellow of the Academy of Pharmaceutical Sciences in September 2010.Patrick Crowley has over 40 years experience in dosage form development in the pharmaceutical industry, in both the UK and USA. He has played key roles in the development of 16 commercial products, including fermentation products, semi synthetics, synthetic structures and a biopharmaceutical product and holds several formulation-related Patents. His interests and publications include drug and product stability, enhancing performance by dosage form design and the application of Quality by Design principles and practices in dosage form development, manufacture and control. 428 pp. Englisch. Codice articolo 9781461410034

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 213,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 11,00
Da: Germania a: Italia
Destinazione, tempi e costi
Immagini fornite dal venditore

Patrick J. Crowley
Editore: Springer US (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovo Rilegato Quantità: 1
Da:
AHA-BUCH GmbH
(Einbeck, Germania)
Valutazione libreria

Descrizione libro Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Controlling the rate, extent and time of a drug s delivery can optimize its performance in many ways, relative to immediate release delivery. Such optimized design requires a broad knowledge base of topics such as gastro intestinal tract physiology, polymer science, and the mechanisms by which drugs are released from the formulated units. Technologies to reduce to practice also need to be carefully considered. Such knowledge must be allied to the physico chemical properties of the drug, its pharmacokinetic behaviors, enzyme susceptibility and other factors that can affect absorption or timecourse in the biosystem. Traditionally, controlled release systems tended to be second-generation products, building on accumulated clinical experience. However, better awareness of the molecular biology of drug action and the promise of biomarkers and personalized medicine may mean that optimizing performance by controlling release may become a first option in new product development. Such optimization may well help reduce the alarming attrition rates that are now prevalent in new drug development.Controlled Release in Oral Drug Delivery provides chapters, dealing with all facets of the above subject matter, and its challenges. Authors have been drawn from academia, providers of excipients and from those designing controlled release systems in industrial R&D and manufacture. The contents provide a unique blend of cutting edge knowledge, data on materials and practical experiences. It is essential text for students, researchers and industrial engineering, formulation and manufacturing technologists as well as quality testing and control functions. Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University in Glasgow, Scotland and the current president of the European Union Federation for Pharmaceutical Sciences. He is the Chief Scientist of Bio-Images Research Group, a Phase II imaging specialist clinical unit in Glasgow Royal Infirmary.Major areas of research have been the study of the behaviour of drug formulations in man. With colleagues at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects of transit on drug absorption and began the investigations into regional drug absorption in man. This was later applied to the design and optimisation of oral dosage forms, in silico modelling of formulations in man and studies on IVIVR. He has published more than 150 papers, six books and over 130 reviews and book chapters. He was made a fellow of the Controlled Release Society in June 2010 and a Fellow of the Academy of Pharmaceutical Sciences in September 2010.Patrick Crowley has over 40 years experience in dosage form development in the pharmaceutical industry, in both the UK and USA. He has played key roles in the development of 16 commercial products, including fermentation products, semi synthetics, synthetic structures and a biopharmaceutical product and holds several formulation-related Patents. His interests and publications include drug and product stability, enhancing performance by dosage form design and the application of Quality by Design principles and practices in dosage form development, manufacture and control. Codice articolo 9781461410034

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 217,00
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 14,99
Da: Germania a: Italia
Destinazione, tempi e costi
Foto dell'editore

Editore: Springer (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovo Rilegato Quantità: 16
Da:
Lucky's Textbooks
(Dallas, TX, U.S.A.)
Valutazione libreria

Descrizione libro Condizione: New. Codice articolo ABLIING23Mar2716030035205

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 219,94
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 69,50
Da: U.S.A. a: Italia
Destinazione, tempi e costi